Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: TNXP

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories
  • Trading Ideas

Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak

By Wayne Duggan
Today, 8:41 AM
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care and biotech stocks on the move.

AEMD

Read More
3 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

By Lisa Levin
Today, 8:41 AM
Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.

AEMD

Read More
1 minute read
  • News

On Saturday Monkeypox Was Declared a Public Health Emergency in New York City

By Charles Gross
Today, 8:41 AM
https://twitter.com/NYCHealthCommr/status/1553510592060727297

AEMD

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

Watching Monkeypox-Related Stocks After FDA Provides Update On Agency Response To Monkeypox Outbreak; FDA Says Important To Note That Already Have An FDA-Approved Vaccine For The Prevention Of Monkeypox Disease And An FDA-Cleared Diagnostic Test

By Bill Haddad
Today, 8:41 AM
-Reuters

AEMD

Read More
1 minute read
  • FDA
  • News

U.S. Health And Human Services Secretary Becerra Says Monkeypox Testing Now 60,000 To 80,000 Per Week

By Benzinga Newsdesk
Today, 8:41 AM
-Reuters

AEMD

Read More
3 minute read
  • Biotech
  • Earnings
  • FDA
  • Financing
  • General
  • Health Care
  • IPOs
  • Large Cap
  • Legal
  • News
  • Penny Stocks
  • Small Cap

Daily Biotech Pulse: GSK’s Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion’s Schizophrenia Candidate

By Vandana Singh
Today, 8:41 AM
Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

Read More
1 minute read
  • FDA
  • News

CDC Set To Make Monkeypox A Nationally Notifiable Condition; New Designation Will Take Effect Aug. 1

By Benzinga Newsdesk
Today, 8:41 AM
-Politico Report

AEMD

Read More
1 minute read
  • FDA
  • News

Bavarian Nordic Is Now Allowed To Deliver Jynneos/Imvanex Smallpox And Monkeypox Vaccine Manufactured At Its Own Site To U.S. And EU Market

By Benzinga Newsdesk
Today, 8:41 AM
-Reuters

AEMD

Read More
1 minute read
  • General
  • Health Care
  • News

‘As of today, 1,092 people have tested positive for orthopoxvirus in NYC, which is presumed to be monkeypox.’ -NYC Healthy

By Bill Haddad
Today, 8:41 AM
https://twitter.com/nycHealthy/status/1551994547760234498

AEMD

Read More
4 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday

By Lisa Levin
Today, 8:41 AM
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.

ABOS

Posts navigation

Previous 1 … 4 5 6 … 20 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service